Inflammation in atherosclerotic cardiovascular disease

por Shah, Prediman K., Lecis, Dalgisio
Publicado 2019

Clinical Features and Management of COVID-19–Associated Hypercoagulability

por Massaro, Gianluca, Lecis, Dalgisio, Martuscelli, Eugenio, Chiricolo, Gaetano, Sangiorgi, Giuseppe Massimo
Publicado 2022

Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers

por Prandi, Francesca Romana, Lecis, Dalgisio, Illuminato, Federica, Milite, Marialucia, Celotto, Roberto, Lerakis, Stamatios, Romeo, Francesco, Barillà, Francesco
Publicado 2022

Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future

por Lecis, Dalgisio, Massaro, Gianluca, Benedetto, Daniela, Di Luozzo, Marco, Russo, Giulio, Mauriello, Alessandro, Federici, Massimo, Sangiorgi, Giuseppe Massimo
Publicado 2023

Biomolecular Mechanisms of Cardiorenal Protection with Sodium-Glucose Co-Transporter 2 Inhibitors

por Prandi, Francesca Romana, Barone, Lucy, Lecis, Dalgisio, Belli, Martina, Sergi, Domenico, Milite, Marialucia, Lerakis, Stamatios, Romeo, Francesco, Barillà, Francesco
Publicado 2022

Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?

por Belli, Martina, Barone, Lucy, Longo, Susanna, Prandi, Francesca Romana, Lecis, Dalgisio, Mollace, Rocco, Margonato, Davide, Muscoli, Saverio, Sergi, Domenico, Federici, Massimo, Barillà, Francesco
Publicado 2023

Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?

por Belli, Martina, Barone, Lucy, Bellia, Alfonso, Sergi, Domenico, Lecis, Dalgisio, Prandi, Francesca Romana, Milite, Marialucia, Galluccio, Chiara, Muscoli, Saverio, Romeo, Francesco, Barillà, Francesco
Publicado 2022